| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Retracted
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
|
N Engl J Med
|
2006
|
6.69
|
|
2
|
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
|
J Clin Oncol
|
2008
|
6.64
|
|
3
|
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.
|
J Thorac Cardiovasc Surg
|
2010
|
4.23
|
|
4
|
Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors.
|
J Thorac Cardiovasc Surg
|
2007
|
4.15
|
|
5
|
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.
|
Ann Thorac Surg
|
2006
|
3.76
|
|
6
|
Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients.
|
Ann Surg
|
2006
|
3.32
|
|
7
|
Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy.
|
J Thorac Cardiovasc Surg
|
2009
|
3.06
|
|
8
|
Outcomes after esophagectomy: a ten-year prospective cohort.
|
Ann Thorac Surg
|
2003
|
2.73
|
|
9
|
Reducing hospital morbidity and mortality following esophagectomy.
|
Ann Thorac Surg
|
2004
|
2.41
|
|
10
|
Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis.
|
Ann Surg
|
2012
|
2.33
|
|
11
|
Risk factors for morbidity after lobectomy for lung cancer in elderly patients.
|
Ann Thorac Surg
|
2009
|
2.19
|
|
12
|
Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.
|
Ann Thorac Surg
|
2007
|
2.17
|
|
13
|
A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer.
|
J Thorac Cardiovasc Surg
|
2003
|
2.07
|
|
14
|
Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.
|
Clin Cancer Res
|
2003
|
1.98
|
|
15
|
Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.
|
J Thorac Cardiovasc Surg
|
2007
|
1.96
|
|
16
|
Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.
|
Cancer
|
2006
|
1.91
|
|
17
|
Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases.
|
Ann Thorac Surg
|
2009
|
1.88
|
|
18
|
Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach.
|
Ann Thorac Surg
|
2007
|
1.66
|
|
19
|
Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate.
|
Ann Thorac Surg
|
2006
|
1.52
|
|
20
|
Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma.
|
Ann Surg Oncol
|
2006
|
1.47
|
|
21
|
Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection.
|
Ann Thorac Surg
|
2011
|
1.47
|
|
22
|
High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.
|
Clin Cancer Res
|
2005
|
1.46
|
|
23
|
A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.
|
Ann Surg
|
2017
|
1.39
|
|
24
|
Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection.
|
Eur J Cardiothorac Surg
|
2011
|
1.34
|
|
25
|
Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy.
|
Ann Thorac Surg
|
2010
|
1.32
|
|
26
|
A cost-minimisation analysis of lobectomy: thoracoscopic versus posterolateral thoracotomy.
|
Eur J Cardiothorac Surg
|
2009
|
1.30
|
|
27
|
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.
|
J Thorac Cardiovasc Surg
|
2003
|
1.28
|
|
28
|
A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia.
|
J Thorac Cardiovasc Surg
|
2010
|
1.22
|
|
29
|
Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.
|
Ann Thorac Surg
|
2006
|
1.19
|
|
30
|
A model for morbidity after lung resection in octogenarians.
|
Eur J Cardiothorac Surg
|
2011
|
1.17
|
|
31
|
Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection.
|
Ann Thorac Surg
|
2004
|
1.13
|
|
32
|
Outcomes of video-assisted thoracoscopic decortication.
|
Ann Thorac Surg
|
2010
|
1.09
|
|
33
|
Outcomes of tracheobronchial stents in patients with malignant airway disease.
|
Ann Thorac Surg
|
2005
|
1.06
|
|
34
|
Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
|
Lung Cancer
|
2005
|
1.05
|
|
35
|
Low morbidity and mortality for bronchoplastic procedures with and without induction therapy.
|
Ann Thorac Surg
|
2005
|
0.96
|
|
36
|
Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.
|
J Thorac Oncol
|
2014
|
0.95
|
|
37
|
Intraoperative techniques to prevent air leaks.
|
Chest Surg Clin N Am
|
2002
|
0.94
|
|
38
|
Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.
|
N Engl J Med
|
2011
|
0.87
|
|
39
|
Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803.
|
J Thorac Cardiovasc Surg
|
2013
|
0.86
|
|
40
|
Neighborhood-level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States.
|
Cancer
|
2012
|
0.86
|
|
41
|
Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.
|
J Nucl Med
|
2006
|
0.83
|
|
42
|
Thoracoscopic sympathectomy in the management of vasomotor disturbances and complex regional pain syndrome of the hand.
|
Orthopedics
|
2004
|
0.83
|
|
43
|
Quality of life outcomes are equivalent after lobectomy in the elderly.
|
J Thorac Cardiovasc Surg
|
2008
|
0.82
|
|
44
|
A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma.
|
Ann Thorac Surg
|
2011
|
0.82
|
|
45
|
Molecular markers for incidence, prognosis, and response to therapy.
|
Surg Oncol Clin N Am
|
2012
|
0.82
|
|
46
|
Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
|
Ann Thorac Surg
|
2006
|
0.79
|
|
47
|
Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection.
|
Ann Thorac Surg
|
2003
|
0.78
|
|
48
|
Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies.
|
Ann Thorac Surg
|
2002
|
0.78
|
|
49
|
A randomized, double blind, placebo controlled clinical trial of the preoperative use of ketamine for reducing inflammation and pain after thoracic surgery.
|
J Anesth
|
2011
|
0.77
|
|
50
|
The surgical management of lung cancer.
|
Cancer Invest
|
2006
|
0.77
|
|
51
|
Computed tomography screening for the early detection of lung cancer.
|
J Natl Compr Canc Netw
|
2006
|
0.77
|
|
52
|
Molecular staging of lung and esophageal cancer.
|
Surg Clin North Am
|
2002
|
0.76
|
|
53
|
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.75
|
|
54
|
Stage I NSCLC: elucidating the prognostic factors.
|
Thorax
|
2009
|
0.75
|
|
55
|
Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.
|
J Clin Oncol
|
2012
|
0.75
|
|
56
|
The Integrated Comprehensive Care Program: A Novel Home Care Initiative After Major Thoracic Surgery.
|
Semin Thorac Cardiovasc Surg
|
2016
|
0.75
|
|
57
|
Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.
|
Ann Surg
|
2017
|
0.75
|
|
58
|
Audit, quality control, and performance in thoracic surgery: a North American perspective.
|
Thorac Surg Clin
|
2007
|
0.75
|
|
59
|
Molecular biologic substaging of stage I NSCLC through immunohistochemistry performed on formalin-fixed, paraffin-embedded tissue.
|
Methods Mol Med
|
2003
|
0.75
|
|
60
|
Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.
|
Semin Thorac Cardiovasc Surg
|
2005
|
0.75
|